Teva to sell "morning after" pill in US without age limit

A federal US court struck down an administration decision to restrict sales of Teva's Plan B contraceptive.

On Friday, the US District Court for the Eastern District of New York (Brooklyn) allowed Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) to sell the Plan B One-Step morning after pill, ordering the pill to be sold without prescriptions regardless of age. Judge Edward Korman, overturned a 2011 decision by the Obama administration which required girls 17 and younger to acquire a subscription to buy the pill.

In response to the decision, legislators in Washington said that they still believe in healthy logic, despite Korman's decision. The Department of Justice, which defended the administration's position in court, may appeal the ruling, a step that could further inflame the political and legal dispute over the morning after pill over the past decade.

Judge Korman said the administration's restrictions on Plan B Next Step were unreasonable. The ruling came after Secretary of Health and Human Services Kathleen Sebelius decided to override a decision by the US Food and Drug Administration (FDA) to sell Plan B to girls 17 and younger without a prescription.

Published by Globes [online], Israel business news - - on April 7, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018